Write the hold in the margin first. Then the labeled milligram. Nothing here is sold or filled.
Pure Health Notes

Margin notes for reading - not a script, not a fill. Open the margin disclaimer.

Gabapentin · practical · PHN-E3

Day-one 300 mg is a start, not a renal-blind standing order

Most gabapentin harm I see is arithmetic. Someone copies a 300 mg three-times-daily habit onto a falling eGFR, or pairs the capsule with an opioid and calls the extra fog 'adjustment.' The label already has the table. The clinic sometimes skips it. This card walks the PHN climb from one 300 mg capsule, the epilepsy 300 mg three-times-daily start, the creatinine-clearance bands, the post-marketing breathing warning, and the one-week minimum taper. Figures follow the Neurontin insert. Your written prescription still wins. Peer-line: check the kidney, then open the bottle.

  • PHN day 1: 300 mg once
  • First filter: eGFR / CrCl
  • Pairing risk: opioids
  • Stop rule: taper ≥1 week
Kidney eGFR box and a 300 mg titration ladder

Read the eGFR before you open the 300 mg bottle

Elimination is almost entirely renal and unchanged. Dose follows clearance, not optimism.

Gabapentin is not metabolized. It leaves in urine. Half-life is 5 to 7 hours when creatinine clearance is decent and about 52 hours when clearance is under 30 mL/min. In anuric adults it is about 132 hours on non-dialysis days and about 3.8 hours during hemodialysis. That stretch is the whole safety story.

A 300 mg capsule in a young adult with CrCl at or above 60 mL/min is a starting brick. The same capsule in an older person whose eGFR has slid into the 20s is already a large fraction of a labeled daily band. I want a recent creatinine, an estimated clearance, and a look at age and muscle mass before I cheer a 'low' start.

Why the molecule exists, and why the GABA name misleads, sits in how a GABA mimic became Neurontin 300 mg. PK detail also lives on the Neurontin 300 mg medicine page. This page is the arithmetic.

PHN: one 300 mg capsule, then 600, then 900

Adult PHN titration from the Neurontin label - only after CrCl is in a band that can hold it.
Day (PHN, fair kidneys)Total dailyHow the 300 mg unit is split
Day 1300 mgOne 300 mg capsule once
Day 2600 mg300 mg twice
Day 3900 mg300 mg three times
Then, if neededToward 1800 mg/dayOften 600 mg three times
Trial range1800-3600 mg/dayNo extra benefit shown above 1800

Adult postherpetic neuralgia on the Neurontin label starts with a single 300 mg dose on day one. Day two is 600 mg as 300 mg twice. Day three is 900 mg as 300 mg three times. Then titrate as needed toward 1800 mg per day, usually 600 mg three times daily. That is the labeled climb when kidneys can hold it.

Trials showed effect from 1800 to 3600 mg per day. Extra benefit above 1800 mg was not demonstrated. I treat 1800 as the usual ceiling unless a specialist has a reason to go higher and the eGFR agrees. Fast climbs buy dizziness and dropouts. Day one is not an efficacy test. It is a fog check.

Do not run this ladder if clearance is already reduced. The renal table below cuts the daily total and often cuts the number of doses. A person on hemodialysis needs a reduced maintenance dose plus a supplemental dose after each session. Copying a PHN ladder from a neighbor is how people get admitted for unsteadiness.

Epilepsy: 300 mg three times a day is a start, not a suggestion

People 12 years and older start at 300 mg three times daily. Recommended maintenance is 300 to 600 mg three times daily. Long-term work tolerated 2400 mg per day. 3600 mg per day appears only in a small, shorter set. The longest gap on a three-times-daily schedule should not exceed 12 hours. Missed evening doses matter because the half-life is short when kidneys work.

Children 3 to 11 start around 10 to 15 mg/kg/day in three doses, then climb over about three days. Ages 3 to 4 usually land near 40 mg/kg/day. Ages 5 to 11 usually land near 25 to 35 mg/kg/day. PHN has no pediatric stamp. Do not borrow the adult 300 mg capsule schedule for a child without a pediatric epilepsy plan.

Food is optional. An aluminum-magnesium antacid cuts bioavailability about 20%. Wait at least two hours after that antacid before the next gabapentin dose. If you split a scored 600 or 800 mg tablet, take the leftover half as the next dose and discard unused halves after 28 days.

Saturable gut: more milligrams, smaller fraction

The 300 mg unit is honest early and leaky late. That is a transporter problem, not a willpower problem.

Bioavailability is about 60% at 900 mg per day, 47% at 1200, 34% at 2400, 33% at 3600, and 27% at 4800 mg per day when given in three divided doses. Climbing from 300 mg three times daily to huge totals buys less drug than the arithmetic on the bottle suggests. It still buys CNS adverse effects.

That is one reason I do not chase 3600 mg for PHN when 1800 mg already failed. The label already said extra benefit was not shown. Saturable absorption is the pharmacokinetic echo of that clinical finding. Split doses beat one giant swallow.

Renal bands from the Neurontin table, not from memory

Neurontin renal table, condensed - match the 300 mg unit to the band, not to a roommate's dose.
Creatinine clearance (mL/min)Total daily rangeExample rhythm
60 or higher900-3600 mg300-1200 mg three times daily
>30 to 59400-1400 mg200-700 mg twice daily
>15 to 29200-700 mg200-700 mg once daily
15100-300 mg100-300 mg once daily
Below 15Reduce in proportionIndividualized
HemodialysisReduced maintenancePlus 125-350 mg after a session

For people 12 and older the insert gives total daily ranges by creatinine clearance, then example regimens. CrCl at or above 60 mL/min: 900 to 3600 mg per day, often 300 to 1200 mg three times daily. CrCl above 30 to 59: 400 to 1400 mg per day, often twice daily. CrCl above 15 to 29: 200 to 700 mg once daily. At 15 mL/min: 100 to 300 mg once daily. Below 15, reduce in proportion to clearance.

Hemodialysis: reduced maintenance plus a post-session supplement of 125 to 350 mg depending on the maintenance band. Pediatric renal impairment was not studied. Older adults need the table even when the creatinine looks 'almost normal' - muscle mass hides a low clearance. Peripheral edema and ataxia already rise with age in the PHN trials.

Opioids, COPD, and the breathing warning

Serious, life-threatening, or fatal respiratory depression is on the insert when gabapentin meets another CNS depressant or a damaged drive to breathe.

Alone, in a healthy adult, breathing risk is low. The danger is the pair: an opioid (morphine, hydrocodone, oxycodone, buprenorphine and the rest), another sedative, or underlying respiratory impairment such as severe COPD. The label tells you to monitor and to consider a low gabapentin start in those settings. A 300 mg capsule is not automatically 'low' if the eGFR is already down.

Morphine can raise gabapentin levels. Hydrocodone exposure falls when Neurontin is added - Cmax and AUC drop in a dose-dependent way in the interaction study. Watch the person, not only the math. Unusual sleepiness, slow breathing, or new confusion is an urgent look, not a 'give it a few days' note.

I want both prescribers to know the pair exists. Chronic pain clinics stack these two drugs out of habit. Habit is how the 2019-era warning earned its ink. FDA communications: FDA.

Taper over at least a week - longer if the dose was high

If the dose is reduced, stopped, or swapped, the label wants a gradual change over a minimum of one week. Longer is reasonable after high totals or long use. Antiepileptic drugs should not be yanked; seizure frequency can rise, including in people who were previously controlled. That warning applies even when gabapentin was used for pain.

Post-marketing reports after abrupt stop list anxiety, insomnia, nausea, pain, and sweating. Rare reports after high, off-label totals include agitation, disorientation, and confusion that settled when the drug was restarted. Physical dependence has not been mapped in formal human studies. The practical rule is still simple: plan a wean. Do not convert a 'not helping' review into a Thursday cliff.

Which uses even deserve a long course is a separate card: what Neurontin 300 mg actually treats. A leftover insomnia script should not be a lifelong bottle, and it still needs a taper on the way out.

Everyday fog, driving, and the AED class suicide note

In PHN trials, dizziness hit 28% on Neurontin versus 8% on placebo. Somnolence hit 21% versus 5%. In epilepsy trials above age 12, somnolence 19% versus 9%, dizziness 17% versus 7%, ataxia 13% versus 6%. Peripheral edema is a PHN-trial regular. Do not drive until you know what a 300 mg step does to you. People are bad at judging their own sleepiness. The label says that out loud.

Antiepileptic drugs as a class raise suicidal thoughts or behavior. Pooled analysis across 11 AEDs: about twice the risk versus placebo (adjusted relative risk 1.8), 0.43% versus 0.24%, roughly one extra case per 530 treated in those short trials. The signal is uncommon and still worth a family watch for new mood change. It is a class note, not a gabapentin-only headline.

Stop and get urgent care for signs of DRESS (fever, nodes, rash, organ involvement) or anaphylaxis and angioedema (lips, tongue, throat, trouble breathing). Early DRESS can show fever or lymphadenopathy before a rash. Hypersensitivity to gabapentin or an excipient is the only labeled contraindication.

Antacids, morphine, and the few interactions that actually move numbers

Because the drug is not metabolized, the CYP card is mostly empty. Phenobarbital parameters look the same with or without gabapentin 300 mg three times daily in the small study. Combined oral contraceptive AUC and half-life barely move. Cimetidine nicks gabapentin clearance about 14% - not a clinic-changing figure.

The interactions I actually annotate: morphine (watch sedation and breathing), hydrocodone (opioid exposure falls; gabapentin AUC up about 14%), and aluminum-magnesium antacids (wait two hours). Alcohol is additive fog and fall risk. Misuse clusters in people with a polysubstance history, sometimes at higher-than-labeled totals for unapproved uses. Screen that history. Watch early refills. Several states now schedule gabapentin even though federal law does not.

Overdose reports include double vision, tremor, slurred speech, drowsiness, altered mentation, and diarrhea. Fatal respiratory depression has been reported with overdose alone and with other depressants. That is a poison-center call, not a wait-and-see. Patient wording: MedlinePlus gabapentin. Insert: DailyMed Neurontin.

What I file on the safety card

Check eGFR. Then decide whether a 300 mg capsule is a start or already a large slice of the daily band. Climb on the PHN ladder only when clearance can hold it. Keep gaps under 12 hours on a three-times-daily epilepsy plan. Watch the opioid pair. Taper at least a week. Do not treat the yellow capsule as a vitamin because the GABA name sounds gentle.

If the indication was never PHN or add-on seizures, put a review date next to the milligrams. If the indication is labeled and the person is still unsteady, look at the kidney before you look at 'sensitivity.' Most of the harm I see was avoidable arithmetic.

Dr. Helena Vasquez portrait, pharmacology margin desk

Reader mail

Reader questions on this article

Answered by Dr. Helena Vasquez, PharmD · Clinical pharmacology & drug safety

The dosing card drew the practical questions. Helena took them at the desk.

I just started an opioid and I already take gabapentin 300 mg. How worried should I be?

Take it seriously. Do not panic. The insert warns about serious, life-threatening, or fatal respiratory depression when gabapentin sits with a CNS depressant - opioids named - or when the drive to breathe is already damaged. Conservative totals, a low gabapentin start if you are newly pairing, and one clinician who knows both bottles. New heavy sleepiness, slow breathing, or a partner who cannot wake you is urgent care, not a 'see how tomorrow goes' plan. FDA's page is the public warning; DailyMed is the full wording.

My eGFR is reduced. Does a 300 mg capsule still count as a small start?

Not automatically. Gabapentin leaves unchanged in urine. When creatinine clearance sits above 30 to 59 mL/min the labeled daily band is already 400 to 1400 mg, often twice daily - not a copied 300 mg three times a day. Between 15 and 29 it is often once daily. At 15 mL/min the whole day may be 100 to 300 mg. Dialysis needs a reduced maintenance dose plus a post-session supplement. Bring the number. Do not borrow a roommate's 300 mg rhythm.

The 300 mg is not helping. Can I just stop this weekend?

No. Even a failed trial needs a wean. The label wants at least one week when you reduce, stop, or swap, and longer after a high total or a long course. Abrupt stop can bring anxiety, insomnia, nausea, sweating, and pain. In epilepsy it can bring extra seizures. Tell the prescriber you want off because the job failed. That is a taper conversation. A Saturday cliff turns a simple review into an avoidable withdrawal week.

How long before I can say the PHN climb from 300 mg is a miss?

Not on day one. Day one is a single 300 mg capsule to see what fog you buy. Day two is 600. Day three is 900. Then you still have to reach a labeled range - often toward 1800 mg per day - and hold it long enough to read a pain score, usually a couple of weeks at a stable total if kidneys allow. Titration days are a tolerability test. Efficacy is judged after a fair dose, not after the first yellow capsule.

Is gabapentin addictive? I have heard both 'never' and 'street drug.'

It is not an opioid for most people, and it is not federally scheduled. Misuse and abuse are in the post-marketing file, mostly in people with a polysubstance history, sometimes at higher-than-labeled totals for unapproved uses. Alone, most patients do not get a reinforcing high. The risk I watch is potentiation of opioids and sedatives, plus early refills. Some states now schedule it. Tell the prescriber if that history is yours. It changes monitoring. It does not automatically deny a labeled PHN course.

I am 78 and I feel drunk on 300 mg at night. Do I stop it myself?

Call, do not yank. Age-related loss of clearance turns a 'tiny' 300 mg into a larger exposure. PHN trials already showed more edema and ataxia as age rose, and a larger treatment effect in people 75 and older that the label links to higher exposure from slower kidneys. Fall risk is real. The fix is usually a lower band from the renal table, not a Friday stop. Bring the eGFR. Ask for a slower wean if the drug is coming off.

Can I have a drink on gabapentin 300 mg?

I would minimize or skip it. Alcohol adds sedation to a drug that already causes dizziness and somnolence in a large slice of PHN and epilepsy trial patients. That is the same depressant-load problem as the opioid pair, just slower and easier to shrug off until a fall. Once you are stable, an occasional small amount is a prescriber question, not a forum rule. Regular heavy drinking plus gabapentin is a poor plan. Mayo Clinic keeps a plain interaction page if you want a second wording.

I take Maalox most evenings. Does that fight the 300 mg capsule?

Yes, a bit. An aluminum-magnesium antacid cuts mean gabapentin bioavailability about 20%. The insert wants at least two hours after that antacid before the next gabapentin dose. If your 300 mg is at bedtime and the antacid is at bedtime, you are donating a fifth of the dose to the sink. Separate them. Food itself only nudges AUC and Cmax about 14%, so I do not fuss about meals the way I fuss about Maalox.

Where do the other two notes sit next to this card?

The GABA-name archive is how a GABA mimic became Neurontin 300 mg. The use map is what it treats and what it does not. The medicine page is Neurontin 300 mg. This card is only the climb, the renal bands, the breathing pair, and the taper. Read the indication before you copy a 300 mg rhythm from someone else's bottle.

General education from a clinician, not personal medical advice. Bring your own history to your own prescriber.

Last Updated

Pure Health Notes

Seven notes, twenty-one reads, three names in the margin.

Write the hold. Then the milligram. Ask Adaeze, Julian, or Helena. This desk does not fill a bottle.

Browse the medicines